Clinical Trial Update: RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial [Phase 2]

View source ↗

Summary

This entry announces a Phase II randomized, double-blind trial of RMT in combination with Durvalumab and chemotherapy in untreated non-small cell lung cancer (a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung
• Lung Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (unspecified regimen)
• Durvalumab (durvalumab)
• RMT

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Adenocarcinoma of Lung, Lung Cancer | Phase 2 | Status: RECRUITING